Factors that impact the transfer and retention of best practices for reducing error in hospitals.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 15192981)

Published in Health Care Manage Rev on June 14, 2004

Authors

Whitney Blair Berta1, Ross Baker

Author Affiliations

1: Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

Articles by these authors

Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet (2012) 1.81

Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy. Hepatology (2009) 1.54

Investigation of coagulopathy in three cases of tiger snake (Notechis ater occidentalis) envenomation. Pathology (2002) 1.46

Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology (2009) 1.44

Protein Z in ischemic stroke and its etiologic subtypes. Stroke (2003) 0.96

Structure-based design of orally bioavailable 1H-pyrrolo[3,2-c]pyridine inhibitors of mitotic kinase monopolar spindle 1 (MPS1). J Med Chem (2013) 0.96

Are myocardial infarction--associated single-nucleotide polymorphisms associated with ischemic stroke? Stroke (2012) 0.91

Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates. Br J Haematol (2014) 0.87

Incidence of cardiovascular outcomes and diabetes mellitus among users of second-generation antipsychotics. J Clin Psychiatry (2013) 0.87

Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban. Thromb Haemost (2013) 0.86

Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study. Thromb Haemost (2007) 0.86

Undiagnosed myeloproliferative disease in cases of intra-abdominal thrombosis: the utility of the JAK2 617F mutation. Clin Gastroenterol Hepatol (2008) 0.86

Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT: results of a large Australian study. Thromb Haemost (2012) 0.82

Management of platelet storage pool deficiency during pregnancy. Aust N Z J Obstet Gynaecol (2003) 0.81

Using SBAR to improve communication in interprofessional rehabilitation teams. J Interprof Care (2010) 0.81

The tissue factor pathway in ischemic stroke. Blood Coagul Fibrinolysis (2006) 0.81

Evaluation of a preoperative team briefing: a new communication routine results in improved clinical practice. BMJ Qual Saf (2011) 0.80

Timing of surgical antibiotic prophylaxis administration: complexities of analysis. BMC Med Res Methodol (2009) 0.80

The value of a quality improvement project in promoting interprofessional collaboration. J Interprof Care (2012) 0.79

On the ball: leadership for patient safety and learning in critical care. J Nurs Adm (2009) 0.78

A rapid flow cytometric technique for the detection of platelet-monocyte complexes, activated platelets and platelet-derived microparticles. Int J Lab Hematol (2008) 0.77

Effect of trunk-restraint training on function and compensatory trunk, shoulder and elbow patterns during post-stroke reach: a systematic review. Disabil Rehabil (2014) 0.77

Reducing errors in identification of von Willebrand disease: the experience of the royal college of pathologists of australasia quality assurance program. Semin Thromb Hemost (2006) 0.77

The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation. Haematologica (2006) 0.76

Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays? Thromb Res (2008) 0.76

Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease. Blood Coagul Fibrinolysis (2009) 0.76

Laboratory diagnosis of von Willebrand disorder: use of multiple functional assays reduces diagnostic error rates. Lab Hematol (2005) 0.75

The costs of developing, implementing, and operating a safety learning system in community practice. J Patient Saf (2013) 0.75

Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generation. Haematologica (2004) 0.75

Editorial: safety and critical care. J Crit Care (2002) 0.75